Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term adriamycin. Found 12 abstracts

Chen XM, Cvetkovic D, Ma CM, Chen LL. Quantitative study of focused ultrasound enhanced doxorubicin delivery to prostate tumor in vivo with MRI guidance. Medical Physics. 2012 May;39(5):2780-6.
Ignatoff JA, Chen YH, Greenberg RE, Pow-Sang JM, Messing EM, Wilding G. Phase II study of intravesical therapy with AD32 in patients with papillary urothelial carcinoma or carcinoma in situ (CIS) refractory to prior therapy with bacillus Calmette-Guerin (E3897): A trial of the Eastern Cooperative Oncology Group. Urologic Oncology-Seminars and Original Investigations. 2009 Sep;27(5):496-501.   PMCID: PMC2743955
Patterson AL, Greenberg RE, Weems L, Bahnson R, Wajsman Z, Israel M, Sweatman T, Webber D, Gulfo J. Pilot study of the tolerability and toxicity of intravesical valrubicin immediately after transurethral resection of superficial bladder cancer. Urology. 2000 Aug;56(2):232-5.
Pulfer SK, Ciccotto SL, Gallo JM. Distribution of small magnetic particles in brain tumor-bearing rats. Journal of Neuro-Oncology. 1999 Jan;41(2):99-105.
Shen HX, Schultz M, Kruh GD, Tew KD. Increased expression of DNA-dependent protein kinase confers resistance to adriamycin. Biochimica Et Biophysica Acta-General Subjects. 1998 Jul 23;1381(2):131-8.
Witte RS, Ryan LM, Schutt AJ, Carbone PP, Engstrom PF. PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinoma. Investigational New Drugs. 1998 Jan;16(4):315-8.
Lattanzi JP, Coia LR, Scher RM, Engstrom PF, Hoffman JP, Eisenberg BF, Sigursdson ER, Epstein BE, Weiner LM. A prospective phase I/II study of intra-arterial chemotherapy and escalating doses of radiation therapy for surgically unresectable carcinoma confined to the liver. Gi Cancer. 1997 Jan;2(2):111-7.
Paul S, Breuninger LM, Tew KD, Shen HX, Kruh GD. ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter. Proceedings of the National Academy of Sciences of the United States of America. 1996 Jul 09;93(14):6929-34.
Breuninger LM, Paul S, Gaughan K, Miki T, Chan A, Aaronson SA, Kruh GD. Expression of Multidrug Resistance-Associated Protein in Nih/3t3 Cells Confers Multidrug-Resistance Associated with Increased Drug Efflux and Altered Intracellular Drug Distribution. Cancer Research. 1995 Nov 15;55(22):5342-7.
Stratmann K, Burgoyne DL, Moore RE, Patterson GM, Smith CD. Hapalosin, a Cyanobacterial Cyclic Depsipeptide with Multidrug- Resistance Reversing Activity. Journal of Organic Chemistry. 1994 Dec 02;59(24):7219-26.
Clapper ML, Kuzmich S, Seestaller LM, Tew KD. Time Course of Glutathione-S-Transferase Elevation in Walker Mammary-Carcinoma Cells Following Chlorambucil Exposure. Biochemical pharmacology. 1993 Feb 09;45(3):683-90.
Borden EC, Kim K, Ryan L, Blum RH, Shiraki M, Tormey DC, Comis RL, Hahn RG, Parkinson DR. Phase-Ii Trials of Interferon-Alpha and Interferon-Beta in Advanced Sarcomas. Journal of Interferon Research. 1992 Dec;12(6):455-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term adriamycin

adriamycin cancer chemotherapy remission hl60 cells mitomycin-c p-glycoprotein cell-lines instillation mechanisms accumulation doxorubicin lines carcinoma analog absolute-configurations ya-subunit gene phase-ii trial magnetic field drug-resistance drug-delivery liposomes Carcinoma in situ responsive prophylaxis xenograft targeted drug delivery ku-autoantigen modified mosher method topoisomerase-ii application catalytic subunit confers resistance controlling inducible expression abnormalities glioma models nitrogen mustards cells transitional-cell carcinoma epirubicin binding Ku tissue distribution particle size ferrofluid gemcitabine Bladder anthracyclines n- modulation trifluoroacetyladriamycin-14-valerate randomized trial actinomycin-d superficial bladder-cancer induction DNA-PK cooperative-oncology-group breast-cancer AD32 n-trifluoroacetyladriamycin-14-valerate ad-32 permeability Intravesical recurrence scytophycins multidrug-resistance disruption scytonema expression gene immunotherapy hl-60 cells multidrug-resistance gene brain drug resistance fam solid tumors v(d)j recombination tumor-cells follow-up strand-break repair element hepatic carcinoma cyclophosphamide albumin microspheres 5-fluorouracil streptozotocin surface Superficial transitional cell carcinoma fluorouracil adenocarcinoma radiation therapy transporter dinoflagellate tumor model metastases liver canalicular membrane aspartate-transcarbamylase conjugation pancreatic carcinoma PALA barrier transport Urothelial carcinoma delivery toxicity 1993 en ll-ultrasound in medicine and biology-v19-p67 nmr intra-arterial MeCCNU hepatocellular-carcinoma 5- glycoprotein management agents identification focused ultrasound doxorubicin-HIFU-prostate cancer phosphorylation
Last updated on Saturday, August 08, 2020